Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitus

Journal of Diabetes

Volumn 5, Issue 4, 2013, Pages 482-491

  Heller, Simon ^a   Bode, Bruce ^b   Kozlovski, Plamen ^c,d   Svendsen, Anne Louise ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NOVO NORDISK A S   (Denmark)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Human blood A1c protein; Hypoglycemia; Insulin aspart; Meta analysis; Regular human insulin

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; ISOPHANE INSULIN;

ARTICLE; BOLUS INJECTION; DIABETES MELLITUS; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GOOD CLINICAL PRACTICE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

HUMAN BLOOD A1C PROTEIN; HYPOGLYCEMIA; INSULIN ASPART; META-ANALYSIS.; REGULAR HUMAN INSULIN;

ADULT; AGED; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ASPART; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887018692     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12060     Document Type: Article

References (27)

1. Home PD, Barriocanal L, Lindholm A. Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers. Eur J Clin Pharmacol. 1999; 55: 199-203.
2. Lindholm A, McEwen J, Riis AP. Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes. Diabetes Care. 1999; 22: 801-805.
3. Mudaliar SR, Lindberg FA, Joyce M etal. Insulin aspart (B28 asp-insulin): A fast-acting analog of human insulin: Absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care. 1999; 22: 1501-1506.
4. Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care. 2000; 23: 583-588.
5. Home PD, Lindholm A, Riis A. Insulin aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: A randomized controlled trial. Diabet Med. 2000; 17: 762-770.
6. Home PD, Hallgren P, Usadel KH etal. Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes. Diabetes Res Clin Pract. 2006; 71: 131-139.
7. Perriello G, Pampanelli S, Porcellati F etal. Insulin aspart improves meal time glycaemic control in patients with type 2 diabetes: A randomized, stratified, double-blind and cross-over trial. Diabet Med. 2005; 22: 606-611.
8. Whitehead A. Meta-Analysis of Controlled Clinical Trials. John Wiley & Sons Ltd, Chichester, 2002.
9. The Cochrane Collaboration. The Cochrane Policy Manual. 2007 [updated 2010]. Available from: http://www.cochrane.org/admin/manual.htm (accessed 9 May 2012).
10. Raskin P, Guthrie RA, Leiter LL, Riis AM, Jovanovic L. Use of insulin aspsart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care. 2000; 23: 583-588.
11. DeVries JH, Lindholm A, Jacobsen JL, Heine RJ, Homet PD. A randomised trial of insulin aspart with intensified basal NPH insulin supplementation in people with type 1 diabetes. Diabet Med. 2003; 20: 312-318.
12. Tamás G, Marre M, Astorga R, Dedov I, Jacobsen J, Lindholm A. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. Diabetes Res Clin Pract. 2001; 54: 105-114.
13. Gao Y, Pan CY, Zou DJ, Xu ZR, Liu XM, Guo XH. Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics. Zhong Yi Xue Za Zhi. 2009; 28: 1960-1963.
14. Thompson SG. Controversies in meta-analysis: The case of trials of serum cholesterol reduction. Stat Methods Med Res. 1993; 2: 173-192.
15. Senn S. Statistical Issues in Drug Development. John Wiley & Sons Ltd, Chichester, 2002.
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986.
17. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-853.
18. Siebenhofer A, Plank J, Berghold A etal. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev. 2006; (2): CD003287.
19. Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H. Efficacy and safety of insulin analogues for the management of diabetes mellitus: A meta-analysis. CMAJ. 2009; 180: 385-397.
20. Manucci E, Monami M, Marchionni N. Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: A meta-analysis. Diabetes Obes Metab. 2009; 11: 53-59.
21. Ahmed AB, Home PD. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Diabetes Care. 1998; 21: 32-37.
22. The Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991; 90: 450-459.
23. Fidler C, Christensen TE, Gillard S. Hypoglycemia: An overview of fear of hypoglycemia, quality of life, and impact on costs. J Med Econ. 2011; 14: 645-655.
24. Brod M, Christensen T, Bushnell DM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: Results from a four-country survey. J Med Econ. 2012; 15: 77-86.
25. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994; 17: 697-703.
26. Choudhary P, Geddes J, Freeman JV, Emery CJ, Heller SR, Frier BM. Frequency of biochemical hypoglycemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: No identifiable differences using continuous glucose monitoring. Diabet Med. 2010; 27: 666-672.
27. Tu E, Twigg SM, Semsarian C. Sudden death in type 1 diabetes: The mystery of the "dead in bed" syndrome. Int J Cardiol. 2010; 138: 91-93.